1 position(s) for US Medical Affairs: Oncology and Portfolio Strategy
Fellowship Position Office Location: Lawrenceville, NJ 08648
POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, offers innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and bio-pharmaceutical industry. This 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships and Bristol Myers Squibb. Program emphasis is in US Medical Affairs: Oncology and Portfolio Strategy.
The US Medical Affairs Oncology & Portfolio Strategy position is a 2-year fellowship that ensures an integrated approach in aligning pan-tumor efforts throughout the medical organization. The fellow will be able to aid the US Medical Teams in developing medical strategies for our marketed products as well as the assets in our pipeline, execute effective launches, and ensure the safe and appropriate use of our medicines by healthcare providers and patients. This fellowship will provide rotational experiences in two key teams within the US Medical organization: Independent Medical Education (IME) for 8 months and Pan-Tumor Medical Strategy for 15 months. During this program, the fellow will:
Drive/or engage in medical strategy tactics, including thought leader interactions, advisory board discussions, gathering field therapeutic area insights, and aligning with oncology medical partners on safety/patient management, health equity, and other pan tumor topics.
Lead the strategic communication, collaboration, and awareness of pan tumor efforts while partnering on execution with functional teams including US and Worldwide Medical, Clinical Development, Commercial, Publications, Medical Information, and Field Medical.
Participate in the execution of pan tumor related deliverables including proactive patient management materials, medical proactive/reactive decks, and training materials for cross-matrix colleagues.
Support high quality, innovative, independent medical education that closes HCP knowledge gaps. Create and lead IME requests for education (RFE) for designated therapeutic areas of focus (strategy development), perform medical review and analysis of IME grant proposals, provide recommendations, and lead IME Review Committee meetings (tactical follow through on strategy).
Analyze outcomes data from BMS-supported medical education activities. Communicate behavioral changes, competence/knowledge gains, learner questions and remaining education gaps to the medical matrix teams. Attend/evaluate continuing medical education programs supported by BMS assessing for compliance, fair-balance and quality of supported medical education programs.
University-based experiences include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and bio-pharmaceutical industry as future leaders. For more information and to apply, please visit our website: http://pharmafellows.rutgers.edu
Do not click the Request Interview button to the right. We do not pre-schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at http://pharmafellows.rutgers.edu
The RPIF program will be conducting initial interviews on a rolling basis virtually (video/teleconference) from October 10th through November 23rd. Candidates MUST use the RPIF website (http://pharmafellows.rutgers.edu) to create a RPIF Candidate Account and upload the required application materialsby the dates noted below. Please see our website for additional important recruitment information and dates.
Once all interviews have been completed, the company will notify candidates of their position-specific candidacy status.
Create an RPIF Candidate Account starting September 23, 2022.
Upload RPIF Application Materials to RPIF Candidate Account starting September 23, 2022.
Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Upload your Letter of Intent and Curriculum Vitae (CV) by October 5, 2022.
Begin securing letters of recommendation because all 3 must be received before you could be considered for an offer. Submit all 3 letters of recommendation by November 10, 2022.
RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.
It is university policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law. As an institution, we value diversity of background and opinion, and prohibit discrimination or harassment on the basis of any legally protected class in the areas of hiring, recruitment, promotion, transfer, demotion, training, compensation, pay, fringe benefits, layoff, termination or any other terms and conditions of employment. For additional information please see the Non-Discrimination Statement at the following web address: http://uhr.rutgers.edu/non-discrimination-statement
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.